Rise Therapeutics
company
About
Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $200K
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$200K
Rise Therapeutics has raised a total of
$200K
in funding over 2 rounds. Their latest funding was raised on
Dec 5, 2017 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 5, 2017 | Seed | $200K | 1 |
TEDCO
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
